14
Reactive arthritis (ReA) following bacterial infection from the urogenital and gastrointestinal tract is widely described but is not typical post-viral infections. This report presents the second case of ReA after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States. A 45-year-old black male with chronic low back pain was hospitalized for 45 days with coronavirus disease 2019 (COVID-19), complicated due to the development of multiorgan failure managed with intubation, extracorporeal membrane oxygenation, and hemodialysis. He was subsequently discharged to an acute rehabilitation facility where he complained of new-onset pain in his shoulders, left elbow, and left knee three weeks after a negative SARS-CoV-2 test. He was readmitted from his acute rehabilitation facility due to recurrent fever and the development of a swollen, warm left knee. Laboratory studies at readmission showed elevated inflammatory markers, negative extensive infectious disease workup, and aseptic inflammatory left knee synovial fluid without crystals. Testing returned negative for most common antibodies seen in immune-mediated arthritides (e.g., rheumatoid arthritis, systemic lupus erythematosus), as well as for common respiratory and gastrointestinal tract pathogens responsible for viral arthritis. The multidisciplinary inpatient medical team deemed the clinical presentation and laboratory findings most consistent with ReA. The patient received a course of oral corticosteroids, followed by a second course due to the recurrence of symptoms weeks after initial treatment and recovery. The current body of medical literature on SARS-CoV-2 pathophysiology supports plausible mechanisms on how this infection may induce ReA. Such a scenario should be considered in the differential of COVID-19-recovered patients presenting with polyarthritis as prompt steroid treatment may help patient recovery.
Loading PDF
7The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
86Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"
Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"
1Peripartum use of Extracorporeal Membrane Oxygenation (ECMO) in a Patient Suffering from COVID-19 Severe Acute Respiratory Distress Syndrome (ARDS): A Case Report
Peripartum use of Extracorporeal Membrane Oxygenation (ECMO) in a Patient Suffering from COVID-19 Severe Acute Respiratory Distress Syndrome (ARDS): A Case Report
Read more66Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
23Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Read more9Perinatal COVID-19.
Perinatal COVID-19.
20Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.
Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e346–e380.
13Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
15Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
17Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
23Guidance for the management of adult patients with coronavirus disease 2019.
In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.
Read more106Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease.
Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease.
8Rear Window—What Can the Gut Tell Us About Long-COVID?
Rear Window—What Can the Gut Tell Us About Long-COVID?
60Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
14Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis
Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis
Read more
Copyright 2026 Cactus Communications. All rights reserved.
